Table 1.
Sensitivity n/N* (%, 95% CI) |
Specificity n/N^ (%, 95% CI) |
PPV n/N¶ (%, 95% CI) |
NPV n/N§ (%, 95% CI) |
|
---|---|---|---|---|
Not on ART (N=213) |
153/211 73 (66–79) |
2/2 100 |
153/153 100 |
2/60 3 (0–8) |
On ART (N=181) |
40/69 58 (46–70) |
74/112 66 (57–75) |
40/78 51 (40–62) |
74/103 72 (63–81) |
All participants (N=394) |
193/280 69 (64–74) |
76/114 67 (62–72) |
193/231 84 (80–88) |
76/163 47 (42–52) |
Number of samples positive by RT-PCR (>2.6 log10 copies/ml) and Up24 (>1.9 log10 fg/ml)/total positive by RT-PCR (>2.6 log10 copies/ml).
Number of samples negative by RT-PCR (≤2.6 log10 copies/ml) and Up24 (≤1.9 log10 fg/ml)/total negative by RT-PCR (≤2.6 log10 copies/ml).
Number of samples positive by RT-PCR (>2.6 log10 copies/ml) and Up24 (>1.9 log10 fg/ml)/total positive by Up24 (>1.9 log10 fg/ml).
Number of samples negative by RT-PCR (≤2.6 log10 copies/ml) and Up24 (≤1.9 log10 fg/ml)/total negative by Up24 (≤1.9 log10 fg/ml).